Tobin C. Schilke

Overview

Tobin C. Schilke received an average of $2M in total compensation, including $331K in salary, at Revance Therapeutics from 2018 to 2021. Tobin Schilke also received $2M at Achaogen in 2017.

Related executives

We found 17 more executives who work or worked at Revance Therapeutics and Achaogen.

Mark Foley

Revance Therapeutics

Chief Executive Officer

Dustin Sjuts

Revance Therapeutics

President

Aubrey Rankin

Revance Therapeutics

Former President, Innovation & Technology

Abhay Joshi

Revance Therapeutics

Chief Operating Officer

Dwight Moxie

Revance Therapeutics

General Counsel

L Browne

Revance Therapeutics

Chief Executive Officer

Caryn McDowell

Revance Therapeutics

General Counsel

Todd Zavodnick

Revance Therapeutics

Former Chief Commercial Officer and President, Aesthetics & Therapeutics

News

You may also like